These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4378819)

  • 21. Selective vasodilatory effect of dipfluzine on vertebral artery in anesthetized dogs.
    Wang YL; He RR
    Zhongguo Yao Li Xue Bao; 1993 Mar; 14(2):124-7. PubMed ID: 8352003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Analysis of a myotropic component in the action of antihistaminic preparations and cardiac glycosides on the collateral coronary circulation].
    Gubarev EA
    Farmakol Toksikol; 1970; 33(4):420-2. PubMed ID: 4402729
    [No Abstract]   [Full Text] [Related]  

  • 23. [Various aspects of the pharmacology of iproveratril, a new synthetic coronary dilator with anti-arrhythmic value].
    Melville KI; Shister HE; Mignault Jde L; Garvey L
    Union Med Can; 1969 Apr; 98(4):592-6. PubMed ID: 5355792
    [No Abstract]   [Full Text] [Related]  

  • 24. The effectiveness of lidoflazine and other coronary vasodilators after oral administration in the trained non-anesthetized dog.
    Jageneau A; Schaper W
    Arzneimittelforschung; 1967 May; 17(5):582-7. PubMed ID: 4969448
    [No Abstract]   [Full Text] [Related]  

  • 25. [Enhancement of the coronary dilator action of i.v. and i.c. administered adenosine following intraduodenal provision of hexobendine in dogs].
    Raberger G; Kraupp O
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):430-1. PubMed ID: 4254341
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of nitroglycerin, dipyridamole, carbocromen, xanthinol nicotinate, and butallylonal on venous return.
    Holtermann W; Lochner W
    Arzneimittelforschung; 1972 Aug; 22(8):1376-81. PubMed ID: 4629177
    [No Abstract]   [Full Text] [Related]  

  • 27. [Piperazine derivatives. 3. Effect of carbonyl- and hydroxy-derivatives (1)].
    Lányi K; Erdélyi I; Tardos L; Lovász M; Institoris E
    Pharmazie; 1970 Mar; 25(3):189-94. PubMed ID: 4393872
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of heptaminol hydrochloride on general, pulmonary and coronary hemodynamics and its effect on heart metabolism].
    Pourrias B; Sergant M; Raynaud G
    Int Z Klin Pharmakol Ther Toxikol; 1970 May; 3(2):190-6. PubMed ID: 5425959
    [No Abstract]   [Full Text] [Related]  

  • 29. Changes in pulsatile coronary blood flow induced by coronary vasodilators.
    Nakamura Y; Nagoshi H; Takei F; Schölkens B; Sasamoto H
    Jpn Heart J; 1970 Sep; 11(5):470-7. PubMed ID: 4991648
    [No Abstract]   [Full Text] [Related]  

  • 30. Drug-induced changes in blood flow in normal and ischaemic regions of the canine myocardium.
    Ledingham IM; Marshall RJ; Parratt JR
    Br J Pharmacol; 1973 Mar; 47(3):626P-627P. PubMed ID: 4730845
    [No Abstract]   [Full Text] [Related]  

  • 31. [Experimental study of pharmacological properties of nialamide].
    Gilev AP; Terekhina AI; Tarasova EI; Khavronina ZP
    Farmakol Toksikol; 1967; 30(3):328-31. PubMed ID: 4386187
    [No Abstract]   [Full Text] [Related]  

  • 32. [Contractility and dynamics of the heart after Oxyfedrin and propranolol].
    Stauch M; Härich BK
    Arztl Forsch; 1971 Apr; 25(4):101-9. PubMed ID: 4396526
    [No Abstract]   [Full Text] [Related]  

  • 33. [Evaluation of the effect of a coronary vasodilator].
    Nakamura Y; Nagoshi H; Takei F; Takahashi M; Matsumura N
    Kokyu To Junkan; 1972 Sep; 20(9):805-9. PubMed ID: 4676839
    [No Abstract]   [Full Text] [Related]  

  • 34. [Coronary vasodilator agents].
    Nakamura Y
    Kokyu To Junkan; 1974 Sep; 22(9):662. PubMed ID: 4475463
    [No Abstract]   [Full Text] [Related]  

  • 35. [Physiology of coronary circulation as the basis for the evaluation of coronary dilator agents].
    Lochner W
    Arzneimittelforschung; 1970 Mar; 20():424-32. PubMed ID: 4989252
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacological effects on coronary reactive hyperemia in conscious dogs.
    Juhran W; Voss EM; Dietmann K; Schaumann W
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 269(1):32-47. PubMed ID: 4252441
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of CRD-401, a coronary vasodilator, on systemic blood flow distribution].
    Okada K; Yamaguchi Y; Innami H; Kosugi I; Yamamura H
    Masui; 1972 Aug; 21(8):781-6. PubMed ID: 4674923
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of oxyfedrine on the blood flow of coronary vessels in intra- and extramural regions (studies on the dog)].
    Düx A; Hahn N; Felix R; Draznin N; Meuser HJ
    Arzneimittelforschung; 1969 Mar; 19(3):300-4. PubMed ID: 5818776
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of parenteral vasodilan and arlidin on cerebral and peripheral blood flow.
    Reiss J; Standish MS; Rosomoff HJ
    Trans Am Neurol Assoc; 1967; 92():281-2. PubMed ID: 5634061
    [No Abstract]   [Full Text] [Related]  

  • 40. [Pharmacologic viewpoint on so-called coronary dilator drugs].
    Faucon G; Evreux JC; Bazaugour R
    Therapie; 1970; 25(2):275-92. PubMed ID: 5526209
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.